Inflammatory Bowel Disease Relief Market to Reach US$ 55.68 Billion by 2034 at 6.78% CAGR
Inflammatory bowel disease continues to present a significant healthcare challenge worldwide, with rising diagnosis rates and increasing demand for advanced treatment options. Continuous innovation in biologics, immunotherapies, and patient-centered care is reshaping the treatment landscape and improving long term disease … Read more